{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:18:26Z","timestamp":1792588706173,"version":"4.5.0"},"reference-count":309,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.pharmthera.2021.108008","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T08:13:27Z","timestamp":1633335207000},"page":"108008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?"],"prefix":"10.1016","volume":"232","author":[{"given":"Abhipree","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles J.","family":"De Blasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.108008_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.metabol.2018.10.004","article-title":"Adiponectin homolog novel osmotin protects obesity\/diabetes-induced NAFLD by upregulating AdipoRs\/PPARalpha signaling in ob\/ob and db\/db transgenic mouse models","volume":"90","author":"Ahmad","year":"2019","journal-title":"Metabolism, Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02912887","article-title":"Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats: A comparative study","volume":"22","author":"Akhileshwar","year":"2007","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41419-018-0851-z","article-title":"Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1\/ERK-dependent necroptosis","volume":"9","author":"Akimoto","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jsps.2014.11.011","article-title":"Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients","volume":"23","author":"Aleidi","year":"2015","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0030","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0035","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1113\/JP273049","article-title":"The role of epicardial adipose tissue in cardiac biology: Classic concepts and emerging roles","volume":"595","author":"Antonopoulos","year":"2017","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0040","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.115.307856","article-title":"Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-\u03b3\/adiponectin signalling","volume":"118","author":"Antonopoulos","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13098-019-0476-0","article-title":"Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases","volume":"11","author":"Bashier","year":"2019","journal-title":"Diabetology and Metabolic Syndrome"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0060","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","article-title":"Adiponectin and its receptors are expressed in bone-forming cells","volume":"35","author":"Berner","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0065","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fendo.2019.00887","article-title":"Curcumin analogs reduce stress and inflammation indices in experimental models of diabetes","volume":"10","author":"Biswas","year":"2019","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/adip.26684","article-title":"Is the lack of adiponectin associated with increased ER\/SR stress and inflammation in the heart?","volume":"3","author":"Boddu","year":"2014","journal-title":"Adipocyte"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-009-9278-8","article-title":"Adiponectin action from head to toe","volume":"37","author":"Brochu-Gaudreau","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0085","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0090","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.2337\/diabetes.54.11.3154","article-title":"The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects","volume":"54","author":"Bruce","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0095","doi-asserted-by":"crossref","first-page":"H719","DOI":"10.1152\/ajpheart.00394.2008","article-title":"PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: Involvement of the PI3-kinase\/Akt and NO pathway","volume":"296","author":"Bulhak","year":"2009","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.631100","article-title":"A new therapeutic candidate for cardiovascular diseases: Berberine","volume":"12","author":"Cai","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0105","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0110","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1210\/jc.2004-0930","article-title":"Expression and regulation of adiponectin and receptor in human and rat placenta","volume":"90","author":"Caminos","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0115","article-title":"AdipoR1\/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0120","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/hr.2014.90","article-title":"Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA\/ROCK suppression in mice","volume":"37","author":"Cao","year":"2014","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0125","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","article-title":"Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte","volume":"279","author":"Chan","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0130","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1210\/jc.2004-1980","article-title":"Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics","volume":"90","author":"Chen","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","article-title":"Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy","volume":"85","author":"Choi","year":"2018","journal-title":"Metabolism, Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/07435800.2013.879165","article-title":"Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice-possible involvement of oxidative stress and autophagy","volume":"39","author":"Chou","year":"2014","journal-title":"Endocrine Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00125-004-1359-x","article-title":"Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes","volume":"47","author":"Civitarese","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","article-title":"Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome","volume":"3","author":"Cool","year":"2006","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0165","first-page":"241","article-title":"AMPK activation: A therapeutic target for type 2 diabetes?","volume":"7","author":"Coughlan","year":"2014","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0170","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/21623945.2020.1817230","article-title":"Effects of the adiponectin mimetic compound ALY688 on glucose and fat metabolism in visceral and subcutaneous rat adipocytes","volume":"9","author":"Da Eira","year":"2020","journal-title":"Adipocyte"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002607","article-title":"Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-analysis of 45,891 individuals","volume":"8","author":"Dastani","year":"2012","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2015.04.028","article-title":"Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110alpha) signaling","volume":"87","author":"De Blasio","year":"2015","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphys.2020.00124","article-title":"Defining the progression of diabetic cardiomyopathy in a mouse model of type 1 diabetes","volume":"11","author":"De Blasio","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0190","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1152\/ajpendo.90731.2008","article-title":"APPL1: Role in adiponectin signaling and beyond","volume":"296","author":"Deepa","year":"2009","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0195","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1210\/me.2011-0082","article-title":"APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway","volume":"25","author":"Deepa","year":"2011","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0200","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1210\/en.2004-0503","article-title":"Induction of adiponectin in skeletal muscle by inflammatory cytokines: In vivo and in vitro studies","volume":"145","author":"Delaigle","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1167\/iovs.17-22920","article-title":"Nrf2 activation is a potential therapeutic approach to attenuate diabetic retinopathy","volume":"59","author":"Deliyanti","year":"2018","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0210","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1042\/CS20160068","article-title":"A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy","volume":"130","author":"Deliyanti","year":"2016","journal-title":"Clinical Science (London, England: 1979)"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0215","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1172\/JCI43464","article-title":"T-cadherin is critical for adiponectin-mediated cardioprotection in mice","volume":"120","author":"Denzel","year":"2010","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb3991","article-title":"Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin","volume":"7","author":"Dhandapany","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2007.04.014","article-title":"Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma","volume":"43","author":"Ding","year":"2007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0230","first-page":"1278","article-title":"Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-beta\/SMAD2\/3 pathway","volume":"6","author":"Ding","year":"2014","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0235","first-page":"21","article-title":"Epicardial adipose tissue, adiponectin and leptin: a potential source of cardiovascular risk in chronic kidney disease","author":"D\u2019Marco","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0240","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.bbadis.2013.05.018","article-title":"Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice","volume":"1832","author":"Dolinsky","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FJC.0000000000000599","article-title":"Cardioprotective effects of metformin","volume":"72","author":"Driver","year":"2018","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0250","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ejcts\/ezu043","article-title":"Pericardial fat is strongly associated with atrial fibrillation after coronary artery bypass graft surgery","volume":"46","author":"Drossos","year":"2014","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0255","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2337\/diabetes.53.9.2473","article-title":"Adiponectin and the development of type 2 diabetes. The atherosclerosis risk in communities study","volume":"53","author":"Duncan","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0260","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: A scientific statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1530\/EJE-12-0688","article-title":"Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome","volume":"168","author":"Eglit","year":"2013","journal-title":"European Journal of Endocrinology of the European Federation of Endocrine Societies"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0270","doi-asserted-by":"crossref","first-page":"H984","DOI":"10.1152\/ajpheart.00428.2011","article-title":"Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling","volume":"301","author":"Essick","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068697","article-title":"Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes","volume":"8","author":"Essick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0280","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/187152512802651015","article-title":"Diabetic cardiovascular disease \u2013 AMP-activated protein kinase (AMPK) as a therapeutic target","volume":"10","author":"Ewart","year":"2012","journal-title":"Cardiovascular & Hematological Agents in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0285","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","article-title":"Adiponectin regulation and function","volume":"8","author":"Fang","year":"2018","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0290","doi-asserted-by":"crossref","first-page":"E721","DOI":"10.1152\/ajpendo.00086.2010","article-title":"An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart","volume":"299","author":"Fang","year":"2010","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0300","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001202","article-title":"Metformin beyond diabetes: Pleiotropic benefits of metformin in attenuation of atherosclerosis","volume":"3","author":"Forouzandeh","year":"2014","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0305","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.01118.2002","article-title":"PPAR-alpha effects on the heart and other vascular tissues","volume":"285","author":"Francis","year":"2003","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0310","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10557-016-6694-x","article-title":"Can adiponectin help us to target diastolic dysfunction?","volume":"30","author":"Francisco","year":"2016","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0315","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0320","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2014.01.043","article-title":"Effect of adiponectin on cardiac beta-catenin signaling pathway under angiotensin II infusion","volume":"444","author":"Fujishima","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0325","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/ATVBAHA.107.156687","article-title":"Adiponectin protects against angiotensin II\u2013induced cardiac fibrosis through activation of PPAR-\u03b1","volume":"28","author":"Fujita","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0330","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1074\/jbc.M117.780734","article-title":"The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2","volume":"292","author":"Fukuda","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0335","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0340","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0345","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.86.2.589","article-title":"Sustained protection by acadesine against ischemia- and reperfusion-induced injury studies in the transplanted rat heart","volume":"86","author":"Galinanes","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diab.23.2.105","article-title":"Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study","volume":"23","author":"Garcia","year":"1974","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0355","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41467-017-02795-4","article-title":"AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation","volume":"9","author":"Gelinas","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0360","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0365","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ars.2007.9.101","article-title":"The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms","volume":"9","author":"Goh","year":"2007","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0375","doi-asserted-by":"crossref","first-page":"32549","DOI":"10.1074\/jbc.M706536200","article-title":"Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase","volume":"282","author":"G\u00f6ransson","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/aps.2017.92","article-title":"Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes","volume":"39","author":"Guo","year":"2018","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0385","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1475-2840-11-94","article-title":"Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats","volume":"11","author":"Guo","year":"2012","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0390","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-8703(03)00403-4","article-title":"Are \u03b2-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials","volume":"146","author":"Haas","year":"2003","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0395","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI62837","article-title":"Potential of gene therapy as a treatment for heart failure","volume":"123","author":"Hajjar","year":"2013","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0400","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2006.08.061","article-title":"Adiponectin and cardiovascular disease: Response to therapeutic interventions","volume":"49","author":"Han","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0405","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/diabetes.51.2.536","article-title":"Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population","volume":"51","author":"Hara","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0410","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"AMP-activated protein kinase: An energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0415","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1038\/s41598-019-39801-2","article-title":"Adiponectin is associated with cardio-metabolic traits in Mexican children","volume":"9","author":"He","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0420","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/11587580-000000000-00000","article-title":"Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: A meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials","volume":"11","author":"Hernandez","year":"2011","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0425","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/ds16-0026","article-title":"Glucagon-like peptide 1 receptor agonists for type 2 diabetes","volume":"30","author":"Hinnen","year":"2017","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0430","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1210\/jc.2003-031458","article-title":"Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance","volume":"89","author":"Hoffstedt","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0440","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molmet.2017.01.002","article-title":"Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis","volume":"6","author":"Holland","year":"2017","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24142545","article-title":"PPARs as nuclear receptors for nutrient and energy metabolism","volume":"24","author":"Hong","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0450","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/08037050410021397","article-title":"Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index","volume":"13","author":"Hong","year":"2004","journal-title":"Blood Pressure"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0455","doi-asserted-by":"crossref","first-page":"545068","DOI":"10.1155\/2015\/545068","article-title":"Total and high molecular weight adiponectin levels and prediction of cardiovascular risk in diabetic patients","volume":"2015","author":"Horakova","year":"2015","journal-title":"International Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0460","doi-asserted-by":"crossref","first-page":"41970","DOI":"10.1074\/jbc.M302403200","article-title":"Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2","volume":"278","author":"Horman","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0465","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel adipose-specific protein adiponectin in T2D patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0470","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0475","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/abbs\/gmy152","article-title":"AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway","volume":"51","author":"Hu","year":"2019","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0480","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1073\/pnas.0403382101","article-title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin","volume":"101","author":"Hug","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0485","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3122\/15572625-11-3-233","article-title":"Metformin-associated lactic acidosis","volume":"11","author":"Hulisz","year":"1998","journal-title":"The Journal of the American Board of Family Practice"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0490","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0495","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijcard.2006.04.016","article-title":"Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects","volume":"115","author":"Iacobellis","year":"2007","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0500","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjcard.2004.06.075","article-title":"Relation between epicardial adipose tissue and left ventricular mass","volume":"94","author":"Iacobellis","year":"2004","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0505","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1113\/EP086407","article-title":"Heart-bound adiponectin, not serum adiponectin, inversely correlates with cardiac hypertrophy in stroke-prone spontaneously hypertensive rats","volume":"102","author":"Inoue","year":"2017","journal-title":"Experimental Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0510","author":"International Diabetes Federation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0515","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1023\/A:1012445316415","article-title":"Structure and functions of classical cadherins","volume":"66","author":"Ivanov","year":"2001","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0520","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.52.7.1655","article-title":"Induction of adiponectin a fat-derived antidiabetic and antiatherogenic factor by nuclear receptors","volume":"52","author":"Iwaki","year":"2003","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108008_bb3000","article-title":"Fibrates for primary prevention of cardiovascular disease events","author":"Jakob","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0525","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5551\/jat.36368","article-title":"Endothelin-1-induced cell hypertrophy in cardiomyocytes is improved by fenofibrate: Possible roles of adiponectin","volume":"24","author":"Jen","year":"2017","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0530","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00125-016-4185-z","article-title":"APPL1 prevents pancreatic beta cell death and inflammation by dampening NFkappaB activation in a mouse model of type 1 diabetes","volume":"60","author":"Jiang","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0535","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41366-019-0383-3","article-title":"Adiponectin homolog osmotin, a potential anti-obesity compound, suppresses abdominal fat accumulation in C57BL\/6 mice on high-fat diet and in 3T3-L1 adipocytes","volume":"43","author":"Jo","year":"2019","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0540","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0545","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0550","doi-asserted-by":"crossref","first-page":"H305","DOI":"10.1152\/ajpheart.00553.2016","article-title":"Activation of PPAR-alpha in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure","volume":"312","author":"Kaimoto","year":"2017","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0555","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ajpath.2012.11.009","article-title":"Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway","volume":"182","author":"Kanamori","year":"2013","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0560","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000492875","article-title":"Targeting peroxisome proliferator activated receptor alpha (PPAR alpha) for the prevention of mitochondrial impairment and hypertrophy in cardiomyocytes","volume":"49","author":"Kar","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235362","article-title":"A novel selective PPAR\u03b1 modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms","volume":"15","author":"Kawanishi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0570","doi-asserted-by":"crossref","first-page":"41792","DOI":"10.1038\/srep41792","article-title":"Muscle-specific overexpression of AdipoR1 or AdipoR2 gives rise to common and discrete local effects whilst AdipoR2 promotes additional systemic effects","volume":"7","author":"Keshvari","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0575","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2217\/clp.09.43","article-title":"AMP-activated protein kinase in the heart: Role in cardiac glucose and fatty acid metabolism","volume":"4","author":"Kewalramani","year":"2009","journal-title":"Clinical Lipidology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0580","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3390\/ijms19113464","article-title":"Elucidating the beneficial role of PPAR agonists in cardiac diseases","volume":"19","author":"Khuchua","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.16","article-title":"AMPK activators: Mechanisms of action and physiological activities","volume":"48","author":"Kim","year":"2016","journal-title":"Experimental and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0590","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/mol.114.093039","article-title":"Globular adiponectin inhibits ethanol-induced reactive oxygen species production through modulation of NADPH oxidase in macrophages: Involvement of liver kinase B1\/AMP-activated protein kinase pathway","volume":"86","author":"Kim","year":"2014","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0595","article-title":"Discovery of a novel potent peptide agonist to adiponectin receptor 1","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0600","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2009.08.018","article-title":"Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells","volume":"388","author":"Kim","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0605","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0610","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0615","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/oxfordjournals.aje.a112648","article-title":"Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota","volume":"108","author":"Knowler","year":"1978","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104888","article-title":"Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: An in vitro study","volume":"9","author":"Kobashigawa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0625","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00395-015-0495-4","article-title":"Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1","volume":"110","author":"Koentges","year":"2015","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0630","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0635","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0640","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbadis.2014.10.005","article-title":"The molecular targets of resveratrol","volume":"1852","author":"Kulkarni","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0645","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1021\/bi9006258","article-title":"Antagonism of human adiponectin receptors and their membrane progesterone receptor paralogs by TNFalpha and a ceramidase inhibitor","volume":"48","author":"Kupchak","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0650","doi-asserted-by":"crossref","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","article-title":"Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes","volume":"293","author":"Lacombe","year":"2007","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0655","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: A meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0660","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: The forgotten diabetes medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0665","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/en.2003-0288","article-title":"Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0670","article-title":"PEG-BHD1028 peptide regulates insulin resistance and fatty acid \u03b2-oxidation, and mitochondrial biogenesis by binding to two heterogeneous binding sites of adiponectin receptors, AdipoR1 and AdipoR2","volume":"22","author":"Lee","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0675","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12965\/jer.140100","article-title":"Role of adiponectin in metabolic and cardiovascular disease","volume":"10","author":"Lee","year":"2014","journal-title":"Journal of Exercise Rehabilitation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0680","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-016-0309-5","article-title":"PPARs modulate cardiac metabolism and mitochondrial function in diabetes","volume":"24","author":"Lee","year":"2017","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0685","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/549101","article-title":"AMPK-dependent metabolic regulation by PPAR agonists","volume":"2010","author":"Lee","year":"2010","journal-title":"PPAR Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0690","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbrc.2005.12.011","article-title":"AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1","volume":"340","author":"Lee","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0695","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research","volume":"6","author":"Leon","year":"2015","journal-title":"World Journal of Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0700","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2015.03.007","article-title":"Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1","volume":"84","author":"Li","year":"2015","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0705","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3892\/etm.2014.1539","article-title":"Analysis of the association between adiponectin, adiponectin receptor 1 and diabetic cardiomyopathy","volume":"7","author":"Li","year":"2014","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0710","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/etm.2021.9762","article-title":"Pemafibrate suppresses oxidative stress and apoptosis under cardiomyocyte ischemia-reperfusion injury in type 1 diabetes mellitus","volume":"21","author":"Li","year":"2021","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0715","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3892\/mmr.2017.6318","article-title":"Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT\/ANP\/BNP signaling pathway","volume":"15","author":"Li","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0720","article-title":"Adiponectin upregulates miR-133a in cardiac hypertrophy through AMPK activation and reduced ERK1\/2 phosphorylation","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0725","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.taap.2013.09.006","article-title":"Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db\/db mice","volume":"273","author":"Li","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0730","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1111\/j.1582-4934.2009.00711.x","article-title":"Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin","volume":"13","author":"Liang","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0735","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/mol.112.083964","article-title":"Adiponectin ameliorates iron-overload cardiomyopathy through the PPAR\u03b1\u2013PGC-1\u2013dependent signaling pathway","volume":"84","author":"Lin","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0740","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population","volume":"360","author":"Lindsay","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0745","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/dc10-1312","article-title":"Pericardial fat and echocardiographic measures of cardiac abnormalities: The Jackson heart study","volume":"34","author":"Liu","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0750","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fphys.2017.00611","article-title":"Osmotin protects H9c2 cells from simulated ischemia-reperfusion injury through AdipoR1\/PI3K\/AKT signaling pathway","volume":"8","author":"Liu","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0755","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1210\/en.2006-0708","article-title":"Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes","volume":"148","author":"Liu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0760","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fnins.2017.00558","article-title":"Curcumin activates AMPK pathway and regulates lipid metabolism in rats following prolonged clozapine exposure","volume":"11","author":"Liu","year":"2017","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0765","doi-asserted-by":"crossref","first-page":"d1309","DOI":"10.1136\/bmj.d1309","article-title":"Comparative cardiovascular effects of thiazolidinediones: Systematic review and meta-analysis of observational studies","volume":"342","author":"Loke","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0770","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12933-019-0860-y","article-title":"Metformin in patients with and without diabetes: A paradigm shift in cardiovascular disease management","volume":"18","author":"Luo","year":"2019","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0775","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/14756366.2017.1284067","article-title":"A potent peptide as adiponectin receptor 1 agonist to against fibrosis","volume":"32","author":"Ma","year":"2017","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0780","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0785","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (dioseost abundant gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0790","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tcm.2014.09.005","article-title":"Impact of obesity on cardiac metabolism, fibrosis, and function","volume":"25","author":"Mahajan","year":"2015","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0795","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncb1404","article-title":"APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function","volume":"8","author":"Mao","year":"2006","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0800","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.112.001133","article-title":"Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels","volume":"127","author":"Margaritis","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0805","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0810","doi-asserted-by":"crossref","first-page":"32790","DOI":"10.1074\/jbc.M111.245985","article-title":"Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism","volume":"286","author":"Maruyama","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0815","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0820","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/en.2014-1618","article-title":"Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice","volume":"156","author":"Matsuda","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0825","doi-asserted-by":"crossref","first-page":"T17","DOI":"10.1530\/JOE-12-0232","article-title":"Role of adipokines in cardiovascular disease","volume":"216","author":"Mattu","year":"2013","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0835","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2165\/11208090-000000000-00000","article-title":"Fenofibrate: A review of its use in dyslipidaemia","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0840","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0845","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/adip.24953","article-title":"Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity","volume":"2","author":"Meyer","year":"2013","journal-title":"Adipocyte"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0850","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(04)00117-5","article-title":"APPL links Rab5 to nuclear signal transduction","volume":"116","author":"Miaczynska","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0855","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0860","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1900\/RDS.2017.14.311","article-title":"Variations in ADIPOR1 but not ADIPOR2 are associated with hypertriglyceridemia and diabetes in an admixed Latin American population","volume":"14","author":"Mora-Garcia","year":"2017","journal-title":"The Review of Diabetic Studies"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0865","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF02850002","article-title":"Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hypertensive patients with type 2 diabetes","volume":"24","author":"Mori","year":"2007","journal-title":"Advances in Therapy"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0870","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2215\/CJN.08160910","article-title":"Lipotoxicity in diabetic nephropathy: The potential role of fatty acid oxidation","volume":"5","author":"Murea","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0875","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fphar.2015.00149","article-title":"Extracellular signal-regulated kinases 1\/2 as regulators of cardiac hypertrophy","volume":"6","author":"Mutlak","year":"2015","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0880","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.metabol.2004.08.012","article-title":"A protective effect of adiponectin against oxidative stress in Japanese Americans: The association between adiponectin or leptin and urinary isoprostane","volume":"54","author":"Nakanishi","year":"2005","journal-title":"Metabolism, Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0885","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a021483","article-title":"Isolation of GBP28 a novel gelatin binding protein purified from human plasma","volume":"120","author":"Nakano","year":"1996","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0890","first-page":"253","article-title":"The cardio-protective signaling and mechanisms of adiponectin","volume":"2","author":"Nanayakkara","year":"2012","journal-title":"American Journal of Cardiovascular Disease"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0895","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0900","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","article-title":"Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists","volume":"281","author":"Nawrocki","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115569","article-title":"AdipoRon and other adiponectin receptor agonists as potential candidates in cancer treatments","volume":"22","author":"Nigro","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0910","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00795-007-0366-7","article-title":"Pathophysiological significance of adiponectin","volume":"40","author":"Nishida","year":"2007","journal-title":"Medical Molecular Morphology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0915","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0920","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","article-title":"Rosiglitazone revisited: An updated meta-analysis of risk for myocardial infarction and cardiovascular mortality","volume":"170","author":"Nissen","year":"2010","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0925","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12872-017-0509-2","article-title":"Low adiponectin is associated with diastolic dysfunction in women: A cross-sectional study from the Tromso study","volume":"17","author":"Norvik","year":"2017","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0930","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1753-0407.12239","article-title":"Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls","volume":"7","author":"Ofstad","year":"2015","journal-title":"Journal of Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0935","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","article-title":"Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype","volume":"285","author":"Ohashi","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0940","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0945","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0950","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fendo.2019.00539","article-title":"Potential adiponectin receptor response modifier therapeutics","volume":"10","author":"Otvos","year":"2019","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0955","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide-based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"BMC Biotechnology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0960","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fchem.2014.00093","article-title":"Development of second generation peptides modulating cellular adiponectin receptor responses","volume":"2","author":"Otvos","year":"2014","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0965","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3389\/fphys.2018.01752","article-title":"Linking arrhythmias and adipocytes: Insights, mechanisms, and future directions","volume":"9","author":"Pabon","year":"2018","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0970","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with Empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0975","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0980","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2796.2008.02007.x","article-title":"Circulating serum adiponectin levels in patients with coronary artery disease: Relationship to atherosclerotic burden and cardiac function","volume":"264","author":"Patel","year":"2008","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0985","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0975-3583.89805","article-title":"Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function","volume":"2","author":"Patil","year":"2011","journal-title":"Journal of Cardiovascular Disease Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0990","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fphys.2017.00227","article-title":"Lack of effects of metformin and AICAR chronic infusion on the development of hypertension in dahl salt-sensitive rats","volume":"8","author":"Pavlov","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb0995","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.febslet.2005.07.098","article-title":"Adiponectin is synthesized and secreted by human and murine cardiomyocytes","volume":"579","author":"Pineiro","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1000","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1005","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.atherosclerosis.2007.06.022","article-title":"Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men","volume":"197","author":"Pischon","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210654","article-title":"Activation of AMPK\/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I\/R) injury in rats","volume":"14","author":"Potenza","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the Pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1042\/CS20170063","article-title":"Phosphoinositide 3-kinase (p110alpha) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction","volume":"131","author":"Prakoso","year":"2017","journal-title":"Clinical Science (London, England: 1979)"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1025","doi-asserted-by":"crossref","first-page":"H840","DOI":"10.1152\/ajpheart.00632.2019","article-title":"Enhanced cardiac phosphoinositide 3-kinase (p110\u03b1) using gene therapy attenuates cardiac remodeling in type 2 diabetic mice","volume":"318","author":"Prakoso","year":"2020","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1030","article-title":"Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart","author":"Prakoso","year":"2021","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1042\/CS20210052","article-title":"Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy \u2013 Current and future perspectives","volume":"135","author":"Prakoso","year":"2021","journal-title":"Clinical Science"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1040","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1159\/000354516","article-title":"Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK\/uncoupling protein 2 pathway","volume":"32","author":"Pu","year":"2013","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1050","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/en.2013-2011","article-title":"Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy","volume":"155","author":"Qi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omtn.2017.07.004","article-title":"Activation of AMPK attenuated cardiac fibrosis by inhibiting CDK2 via p21\/p27 and miR-29 family pathways in rats","volume":"8","author":"Qi","year":"2017","journal-title":"Molecular Therapeutics of Nucleic Acids"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1060","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1023\/B:PHAM.0000041444.06122.8d","article-title":"Peroxisome proliferator-activated receptor (PPAR)-alpha: A pharmacological target with a promising future","volume":"21","author":"van Raalte","year":"2004","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1065","first-page":"1308","article-title":"Effect of A-769662, a direct AMPK activator, on Tlr-4 expression and activity in mice heart tissue","volume":"19","author":"Rameshrad","year":"2016","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/oby.2006.5","article-title":"Adiponectin receptors in human adipose tissue effects of obesity weight loss and fat depots","volume":"14","author":"Rasmussen","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1463-1326.2011.01527.x","article-title":"Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome","volume":"14","author":"Rinaldi","year":"2012","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1080","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2015\/785783","article-title":"AICAR protects against high palmitate\/high insulin-induced intramyocellular lipid accumulation and insulin resistance in HL-1 cardiac cells by inducing PPAR-target gene expression","volume":"2015","author":"Rodriguez-Calvo","year":"2015","journal-title":"PPAR Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin an old but still the best treatment for type 2 diabetes","volume":"5","author":"Rojas","year":"2013","journal-title":"Diabetology and Metabolic Syndrome"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCULATIONAHA.107.743062","article-title":"Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample","volume":"117","author":"Rosito","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1105","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1110","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","article-title":"Metformin prevents progression of heart failure in dogs: Role of AMP-activated protein kinase","volume":"119","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diabres.2015.12.003","article-title":"Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide","volume":"113","author":"Savvidou","year":"2016","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1120","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1074\/jbc.RA118.001801","article-title":"A collagen domain-derived short adiponectin peptide activates APPL1 and AMPK signaling pathways and improves glucose and fatty acid metabolisms","volume":"293","author":"Sayeed","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00041433-200306000-00008","article-title":"Lipotoxicity: When tissues overeat","volume":"14","author":"Schaffer","year":"2003","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1130","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1135","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2337\/diabetes.53.6.1412","article-title":"Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes","volume":"53","author":"Schrauwen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1140","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3109\/14756366.2015.1063622","article-title":"New synthetic AICAR derivatives with enhanced AMPK and ACC activation","volume":"31","author":"Scudiero","year":"2016","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1145","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.0308061100","article-title":"The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress","volume":"101","author":"Shaw","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1150","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00456.2009","article-title":"Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice","volume":"298","author":"Shen","year":"2010","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.yjmcc.2007.03.808","article-title":"Adiponectin protects against the development of systolic dysfunction following myocardial infarction","volume":"42","author":"Shibata","year":"2007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1160","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1137","article-title":"Adiponectin-mediated modulation of hypertrophic signals in the heart","volume":"10","author":"Shibata","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1253\/circj.CJ-09-0057","article-title":"Adiponectin and cardiovascular disease","volume":"73","author":"Shibata","year":"2009","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1170","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1295","article-title":"Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2\u2014Dependent mechanisms","volume":"11","author":"Shibata","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1175","first-page":"134","article-title":"Adiponectin synthesis, secretion and extravasation from circulation to interstitial space","volume":"36","author":"da Silva Rosa","year":"2021","journal-title":"Physiology (Bethesda, Md.)"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1180","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.2337\/db13-1619","article-title":"Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes","volume":"63","author":"Singh","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1185","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/med.21565","article-title":"Health benefits of resveratrol: Evidence from clinical studies","volume":"39","author":"Singh","year":"2019","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1190","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","article-title":"Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis","volume":"57","author":"Singh","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1195","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/eurheartj\/ehn136","article-title":"Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy","volume":"29","author":"Skurk","year":"2008","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1200","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Archives of Medical Science"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1742-7843.2008.00234.x","article-title":"Metformin induces cardioprotection against ischaemia\/reperfusion injury in the rat heart 24 hours after administration","volume":"103","author":"Solskov","year":"2008","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1210","doi-asserted-by":"crossref","first-page":"G739","DOI":"10.1152\/ajpgi.00432.2010","article-title":"Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells","volume":"301","author":"Sozio","year":"2011","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3934\/molsci.2017.1.62","article-title":"The functional roles of T-cadherin in mammalian biology","volume":"4","author":"Sternberg","year":"2017","journal-title":"AIMS Molecular Science"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1220","series-title":"Handbook of biologically active peptides","first-page":"983","article-title":"Adiponectin","author":"Steyn","year":"2013"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1225","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s42255-019-0041-z","article-title":"Metabolic messengers: Adiponectin","volume":"1","author":"Straub","year":"2019","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1230","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/ATVBAHA.117.309630","article-title":"Activation of adiponectin receptor regulates proprotein convertase subtilisin\/kexin type 9 expression and inhibits lesions in ApoE-deficient mice","volume":"37","author":"Sun","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1235","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41401-020-0472-9","article-title":"AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models","volume":"42","author":"Sun","year":"2021","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1240","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","article-title":"Statins activate AMP-activated protein kinase in vitro and in vivo","volume":"114","author":"Sun","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/met.2007.0029","article-title":"Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans","volume":"6","author":"Swarbrick","year":"2008","journal-title":"Metabolic Syndrome and Related Disorders"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.metabol.2018.01.010","article-title":"Novel phytopeptide osmotin mimics preventive effects of adiponectin on vascular inflammation and atherosclerosis","volume":"83","author":"Takahashi","year":"2018","journal-title":"Metabolism, Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1255","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCHEARTFAILURE.114.001279","article-title":"Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction","volume":"7","author":"Tanaka","year":"2014","journal-title":"Circulation. Heart Failure"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41598-018-37115-3","article-title":"Adiponectin promotes muscle regeneration through binding to T-cadherin","volume":"9","author":"Tanaka","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1265","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00239-004-0375-2","article-title":"PAQR proteins: A novel membrane receptor family defined by an ancient 7-transmembrane pass motif","volume":"61","author":"Tang","year":"2005","journal-title":"Journal of Molecular Evolution"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1270","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.106.666941","article-title":"Adiponectin cardioprotection after myocardial ischemia\/reperfusion involves the reduction of oxidative\/nitrative stress","volume":"115","author":"Tao","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1275","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s13300-021-01058-2","article-title":"Efficacy and side effect profile of different formulations of metformin: A systematic review and meta-analysis","volume":"12","author":"Tarry-Adkins","year":"2021","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1280","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CS20160491","article-title":"Are targeted therapies for diabetic cardiomyopathy on the horizon?","volume":"131","author":"Tate","year":"2017","journal-title":"Clinical Science (London, England: 1979)"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1285","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1159\/000443044","article-title":"Globular adiponectin inhibits the apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation via the AdipoR1-mediated pathway","volume":"38","author":"Tian","year":"2016","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","article-title":"The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity","volume":"34","author":"Timm","year":"2020","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1295","doi-asserted-by":"crossref","first-page":"H1619","DOI":"10.1152\/ajpheart.00965.2013","article-title":"A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake","volume":"306","author":"Timmermans","year":"2014","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1300","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.2337\/diabetes.54.12.3358","article-title":"Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: Comparison of activation of PPARalpha, PPARgamma, and their combination","volume":"54","author":"Tsuchida","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1305","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db07-1552","article-title":"Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action","volume":"57","author":"Turner","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1310","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.2009.172320","article-title":"Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy","volume":"96","author":"Unno","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature21714","article-title":"Structural insights into adiponectin receptors suggest ceramidase activity","volume":"544","author":"Vasiliauskait\u00e9-Brooks","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000147","article-title":"Adiponectin, type 2 diabetes and the metabolic syndrome: Lessons from human genetic studies","volume":"8","author":"Vasseur","year":"2006","journal-title":"Expert Reviews in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1325","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2337\/diabetes.55.03.06.db05-0665","article-title":"Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population","volume":"55","author":"Vaxillaire","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1330","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051095","article-title":"AICAr, a widely used AMPK activator with important AMPK-independent effects: A systematic review","volume":"10","author":"Vi\u0161nji\u0107","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1335","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/VHRM.S59429","article-title":"Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril","volume":"10","author":"Wang","year":"2014","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1345","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.3892\/mmr.2017.7450","article-title":"Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1\/2 cells through the adenosine monophosphateactivated protein kinase signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1350","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1874467211205020264","article-title":"Assessment of cardiac safety for PPAR&#947; agonists in rodent models of heart failure: a translational medicine perspective","volume":"5","author":"Wang","year":"2012","journal-title":"Current Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12944-016-0202-y","article-title":"Adiponectin improves NF-kappaB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice","volume":"15","author":"Wang","year":"2016","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1360","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp078","article-title":"Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase","volume":"82","author":"Wang","year":"2009","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1365","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1152\/ajpendo.00663.2009","article-title":"Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury","volume":"298","author":"Wang","year":"2010","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1370","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tem.2017.03.004","article-title":"Cardiovascular adiponectin resistance: The critical role of adiponectin receptor modification","volume":"28","author":"Wang","year":"2017","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1375","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/db11-0985","article-title":"Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation","volume":"61","author":"Warren","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1380","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and T2D-association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1385","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/db06-1230","article-title":"Ca2+\/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation","volume":"56","author":"Witczak","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1390","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1395","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbrc.2004.08.145","article-title":"Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes","volume":"323","author":"Wolf","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1400","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000119","article-title":"Gene therapy to treat cardiovascular disease","volume":"2","author":"Wolfram","year":"2013","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1405","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.0403760101","article-title":"A family of Acrp30 adiponectin structural and functional paralogs","volume":"101","author":"Wong","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1410","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.bjp.0707343","article-title":"Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells","volume":"151","author":"Woollhead","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1415","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/ijms.10001","article-title":"Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention","volume":"11","author":"Wu","year":"2014","journal-title":"International Journal of Medical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1420","doi-asserted-by":"crossref","first-page":"4219735","DOI":"10.1155\/2016\/4219735","article-title":"Exenatide activates the APPL1-AMPK-PPARalpha axis to prevent diabetic cardiomyocyte apoptosis","volume":"2016","author":"XiaoTian","year":"2016","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1425","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1152\/ajpendo.00427.2010","article-title":"APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway","volume":"300","author":"Xin","year":"2011","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1430","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.0000140766.52771.6D","article-title":"Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes","volume":"110","author":"Xu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1435","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1016\/j.febslet.2005.11.019","article-title":"Adiponectin inhibits toll-like receptor family-induced signaling","volume":"579","author":"Yamaguchi","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1440","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-020-0823-5","article-title":"Pemafibrate, a new selective PPARalpha modulator: Drug concept and its clinical applications for dyslipidemia and metabolic diseases","volume":"22","author":"Yamashita","year":"2020","journal-title":"Current Atherosclerosis Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1445","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1450","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"Adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1455","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1460","article-title":"The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1465","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2018.10.004","article-title":"Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis","volume":"124","author":"Yao","year":"2018","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1470","doi-asserted-by":"crossref","first-page":"130636","DOI":"10.1155\/2010\/130636","article-title":"AMP-activated protein kinase activation during cardioplegia-induced hypoxia\/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress","volume":"2010","author":"Yeh","year":"2010","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1475","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/bbrc.2001.5134","article-title":"Change in expression of GBP28\/adiponectin in carbon tetrachloride-administrated mouse liver","volume":"285","author":"Yoda-Murakami","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1480","first-page":"7218","article-title":"PPARalpha activation alleviates damage to the cytoskeleton during acute myocardial ischemia\/reperfusion in rats","volume":"17","author":"Yuan","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1485","first-page":"7218","article-title":"PPAR\u03b1 activation alleviates damage to the cytoskeleton during acute myocardial ischemia\/reperfusion in rats","volume":"17","author":"Yuan","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1490","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCRESAHA.111.255505","article-title":"AMP-activated protein kinase regulation and biological actions in the heart","volume":"111","author":"Zaha","year":"2012","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1495","first-page":"672","article-title":"Curcumin-loaded PEG-PDLLA nanoparticles for attenuating palmitate-induced oxidative stress and cardiomyocyte apoptosis through AMPK pathway","volume":"44","author":"Zhang","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1500","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00109-018-1696-8","article-title":"AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload","volume":"96","author":"Zhang","year":"2018","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1505","doi-asserted-by":"crossref","first-page":"E1436","DOI":"10.1152\/ajpendo.00445.2013","article-title":"Adiponectin inhibits oxidative\/nitrative stress during myocardial ischemia and reperfusion via PKA signaling","volume":"305","author":"Zhang","year":"2013","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1510","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00577.2014","article-title":"AdipoRON, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings","volume":"309","author":"Zhang","year":"2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1515","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2020.09.035","article-title":"Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress","volume":"533","author":"Zhao","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1520","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.3892\/mmr.2017.7033","article-title":"AMPK activation restores ischemic post-conditioning cardioprotection in STZ-induced type 1 diabetic rats: Role of autophagy","volume":"16","author":"Zhou","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1525","doi-asserted-by":"crossref","first-page":"22426","DOI":"10.1074\/jbc.M109.028357","article-title":"Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1\/LKB1-dependent and phospholipase C\/Ca2+\/Ca2+\/calmodulin-dependent protein kinase kinase-dependent pathways","volume":"284","author":"Zhou","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1530","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4161\/auto.6.8.13478","article-title":"Autophagy: Roles in obesity-induced ER stress and adiponectin downregulation in adipocytes","volume":"6","author":"Zhou","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1535","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: Part I","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108008_bb1540","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"The New England Journal of Medicine"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:23:56Z","timestamp":1759011836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":309,"alternative-id":["S0163725821002102"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108008"}}